A whopping one in eight adults in the US have tried GLP-1 medications like Ozempic and Wegovy, but despite their massive ...

People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Ozempic side effects that are more common in females vs. males include nausea, vomiting, dizziness, and headache. Females ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

No, it’s true. I am a diabetic and Ozempic is for diabetics, it is not for fat people.” Ozempic is a brand name for ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye condition ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.